BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scott ES, Fulcher GR, Clifton-Bligh RJ. Sensor-augmented CSII therapy with predictive low-glucose suspend following total pancreatectomy. Endocrinol Diabetes Metab Case Rep 2017;2017:17-0093. [PMID: 29118986 DOI: 10.1530/EDM-17-0093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Schöttler H, Auzanneau M, Best F, Braune K, Freff M, Heidtmann B, Jung R, Karges B, Klee D, Müller A, Schierloh U, Vogel C, Holl RW. Insulinpumpe, kontinuierliche und kapilläre Glukosemessung bei Kindern, Jugendlichen und Erwachsenen mit Diabetes mellitus: Daten des DPV-Registers zwischen 1995 und 2019. Diabetologie und Stoffwechsel 2020;15:477-86. [DOI: 10.1055/a-1259-1190] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Shivaprasad C, Aiswarya Y, Kejal S, Sridevi A, Anupam B, Ramdas B, Gautham K, Aarudhra P. Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus. J Diabetes Sci Technol 2021;15:134-40. [PMID: 31282179 DOI: 10.1177/1932296819860133] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
3 Ziegler R, Heinemann L, Freckmann G, Schnell O, Hinzmann R, Kulzer B. Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM. J Diabetes Sci Technol 2021;15:684-94. [PMID: 32064909 DOI: 10.1177/1932296820905577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]